Loading…
Ultrasensitive determination of pyrroloquinoline quinone in human plasma by HPLC with chemiluminescence detection using the redox cycle of quinone
[Display omitted] •HPLC-CL method was developed for PQQ analysis using the redox cycle of quinone.•The method was ultrasensitive to PQQ with LOD of 1.08nmol/L plasma (0.27nM).•A novel solid phase extraction (SPE) method was developed for PQQ from human plasma.•The developed SPE method was simple, fa...
Saved in:
Published in: | Journal of pharmaceutical and biomedical analysis 2017-10, Vol.145, p.814-820 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [Display omitted]
•HPLC-CL method was developed for PQQ analysis using the redox cycle of quinone.•The method was ultrasensitive to PQQ with LOD of 1.08nmol/L plasma (0.27nM).•A novel solid phase extraction (SPE) method was developed for PQQ from human plasma.•The developed SPE method was simple, fast, and efficient (recovery >95%).•The method was applied to monitor PQQ in human plasma after administration of PQQ.
A fast, accurate, and ultrasensitive high-performance liquid chromatography method with chemiluminescence detection (HPLC-CL) was optimized and validated for the determination of pyrroloquinoline quinone (PQQ) concentration in human plasma following solid-phase extraction (SPE). This method is based on the redox cycle of the reaction between PQQ and dithiothreitol, which generates reactive oxygen species that can be detected using luminol as a CL probe. The isocratic HPLC system comprised an ODS column and 4.0mM tetra-n-butylammonium bromide in Tris-HNO3 buffer (pH 8.8; 50mM)-acetonitrile (7:3, v/v) as mobile phase. A novel, rapid, and simple SPE method was also developed providing excellent %recovery (≥95.2%) for PQQ from human plasma samples. The proposed method was linear over the range of 4.0–400nmol/L plasma of PQQ with a lower detection limit (S/N=3) of 1.08 nmol/L plasma (0.27nM). The method was successfully implemented to determine PQQ concentration in the plasma of healthy individuals after administration of PQQ supplements. |
---|---|
ISSN: | 0731-7085 1873-264X |
DOI: | 10.1016/j.jpba.2017.08.008 |